Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on: November 11,2024 0

Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on:November 11,2024 0

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on: January 11,2024 15

New approach to 'punishment and reward' method of AI training offers potential for aggressive cancers

byUniversity of SurreyCredit: Unsplash/CC0 Public DomainA new "outside-the-box" method of teaching artificial intelligence (AI) models to make decisions could provide hope for finding

Updated on:January 11,2024 15

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on: January 03,2024 9

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco

Updated on:January 03,2024 9

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on: March 01,2024 20

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

Updated on:March 01,2024 20

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on: January 15,2024 12

Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouragin

Updated on:January 15,2024 12

Late effects of treatment hinder independence of adult survivors of childhood brain tumors

by St. Jude Children's Research HospitalCorresponding author Tara Brinkman, PhD, and Gregory Armstrong, MD, MSCE, investigated six aspects of independence among St. Jude Lifetime Cohort parti

Updated on: April 10,2024 19

Late effects of treatment hinder independence of adult survivors of childhood brain tumors

by St. Jude Children's Research HospitalCorresponding author Tara Brinkman, PhD, and Gregory Armstrong, MD, MSCE, investigated six aspects of independence among St. Jude Lifetime Cohort parti

Updated on:April 10,2024 19

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14

Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer: study

by University of Texas M. D. Anderson Cancer CenterVassiliki Papadimitrakopoulou, M.D. Credit: MD Anderson Cancer CenterA multi-center study led by researchers at The University of Texas MD Ander

Updated on: May 23,2024 5

Liquid biopsy as effective as tissue biopsy for non-small cell lung cancer: study

by University of Texas M. D. Anderson Cancer CenterVassiliki Papadimitrakopoulou, M.D. Credit: MD Anderson Cancer CenterA multi-center study led by researchers at The University of Texas MD Ander

Updated on:May 23,2024 5

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C

Updated on: March 30,2024 13

ASCO: liquid biopsy accurate for detecting colorectal cancer

(HealthDay)—Liquid biopsy that identifies circulating tumor cells in a blood sample has high accuracy for detecting colorectal cancer (CRC), according to a study presented at the American Society of C

Updated on:March 30,2024 13

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on: August 28,2024 0

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on:August 28,2024 0

New inflammatory biomarker predicts elevated thrombosis risk in cancer patients

by Medical University of ViennaCredit: Wikimedia CommonsCancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investigat

Updated on: March 12,2024 17

New inflammatory biomarker predicts elevated thrombosis risk in cancer patients

by Medical University of ViennaCredit: Wikimedia CommonsCancer patients are known to have an increased risk of thrombosis. As part of the CATS study, MedUni Vienna researchers have now investigat

Updated on:March 12,2024 17

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on: June 01,2024 3

Researchers pinpoint why lymphoma patients may become resistant to specific therapy

by H. Lee Moffitt Cancer Center & Research InstituteHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0With more targeted

Updated on:June 01,2024 3